Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
Astellas Pharma Inc. (Astellas)24.75M96.29%
Vaxcyte, Inc. (Vaxcyte)846K3.29%
Ipsen Pharma SAS (Ipsen)95K0.37%
Merck Sharp & Dohme Corporation (Merck)8K0.03%
Tasly Biopharmaceuticals Co., Ltd. (Tasly)5K0.02%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States153.73M100.00%
